Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > New Press Release - Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound Gel

<< Previous

Bullboard Posts

Next >>

Comment by MirrorWorldManon Aug 24, 2024 12:41pm

46 Views

Post# 36194688

RE:RE:RE:New Press Release - Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve(TM) Antimicrobial Wound Gel

NR says the market is in the 100's. Good enough for street Cred.. Our collaboration will bring forth an exceptional product to the UAE market which will benefit thousands of patients. We are thrilled about this partnership and look forward to a successful and impactful collaboratio

<< Previous

Bullboard Posts

Next >>

dynaCERT leans into global growth with new HydraGEN orders